Such activating FcγRs present on neutrophils include FcγRI, only present after neutrophil activation, and FcγRIIa, which appears to be the main receptor required for ADCC against cancer cells expressing the tumor antigens HER2/Neu or EGFR (Supplementary Figure 1) (2, 3). The gene discussed is ERBB2; the disease is neoplasm.